Filing Details

Accession Number:
0001179110-12-015131
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-10-12 19:47:28
Reporting Period:
2012-10-10
Filing Date:
2012-10-12
Accepted Time:
2012-10-12 19:47:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1158223 Affymax Inc AFFY Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1344153 H Jeffrey Knapp C/O Affymax, Inc.
4001 Miranda Ave.
Palo Alto CA 94304
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-10-10 14,100 $24.50 28,139 No 4 M Direct
Common Stock Disposition 2012-10-10 14,100 $26.00 14,039 No 4 S Direct
Common Stock Disposition 2012-10-10 914 $25.00 13,125 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2012-10-10 14,100 $0.00 14,100 $24.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,900 2020-01-06 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The award vests on a monthly basis in equal installments during the 48 month period beginning on January 1, 2010.